Spinal Implants Market

Global Spinal Implants Market Size (2023 to 2028)

The global spinal implants market size is expected to grow at a CAGR of 5.34% during the forecast period. This market is estimated to be worth USD 21.26 Billion by 2028 from USD 16.39 Billion in 2022.

Spinal Implants Market Share Insights:

• Based on technology, the motion preservation/non-fusion segment is anticipated to capture the leading share of the global implants market.

• Based on product type, the thoracic fusion and lumbar fusion device segment occupied the major share of the global spinal implants market in 2022.

• Based on surgery type, the minimally invasive surgeries segment held the major share of the global spinal implants market in 2022 and is expected to dominate during the forecast period.

• The Asia Pacific spinal implants market showcased the fastest CAGR of 7.25% during the forecast period.

Most surgeries are not needed in spinal conditions/disorders; however, there are times when they cannot be avoided. When that happens, these deformities are corrected using specially designed spinal instruments that strengthen and stabilize the spine and facilitate fusion. Stainless steel or titanium alloy is generally used to make spinal implants. Sometimes non-metallic compounds are also used.

MARKET DRIVERS:

Augmenting the geriatric and obese population, technological advancements in spine surgery devices, rising incidence and prevalence of spinal disorders, and growing demand for minimally invasive spine surgery are the primary factors driving the growth of the global spinal implants market. According to the National Centre for Health Statistics, every 1 in 4 suffer from chronic low back pain. The flourishing cases of lower back pain end in sciatica or wear and tear conditions leading to conditions affecting the spine.

The global spinal implants market is likely to expand further during the forecast period due to the factors such as increasing demand for MI spine surgeries, availability of innovative spine implants due to the escalation in the approval process, and the emergence of custom fit and 3D printed spine implants. Increased focus on novel product developments to achieve maximum efficiency and high performance, the rapidly growing adoption rate of robotic-assisted surgeries are the factors that are expected to boost growth opportunities for the spine implants market during the forecast period. The research and development proposals for spinal treatments, advancements in healthcare infrastructure, and government funds for research and development of new spine treatment devices accumulate market growth. 

MARKET RESTRAINTS:

High costs involved with the surgeries of spinal implants are one of the major factors hampering the market growth. Limited insurance coverage for spinal implant surgeries in some countries and technological limitations hinder the market growth. In addition, the stringent regulatory environment for spinal implants, the scarcity of skilled professionals, and the competition from alternative treatments are impeding the growth of the spinal implant market. The growing preference for non-surgical treatment options, side-effects associated with spinal surgeries, and poor awareness levels among patients and healthcare providers regarding the benefits of spinal implants are showcasing a negative impact on the market’s growth rate. Product failures, limited availability of certain implant materials and components, and ethical concerns related to the use of animal-derived materials in some spinal implants are some other notable factors acting as obstacles to the market’s growth rate.

Impact of the COVID-19 pandemic on the spinal implants market:

The global spinal implant market has experienced a negative impact from the COVID-19 pandemic. The demand for spinal implants has been slashed due to the postponement of elective surgeries and limited access to healthcare facilities for patients suffering from spinal disorders, as the priority has been given to COVID-19 patients. The supply chain disruptions have further impacted the market growth negatively. The manufacturing and distribution of spinal implants have been hampered due to lockdowns, travel restrictions, and other logistical challenges. During COVID-19, many patients did not opt for spinal implant surgeries and chose alternative treatment options to address their treatment needs. However, the spinal implants market is expected to experience a favorable situation from here on as many healthcare facilities have learned to adapt to the COVID-19 pandemic and working at an increased capacity to meet the growing demand for spinal implant surgeries. The manufacturers have seen this as a significant opportunity to innovate and develop new products to meet the changing needs of the healthcare system. Likewise, the spinal implants market is anticipated to recover quickly from the COVID-19 pandemic and post a healthy CAGR during the forecast period.

REPORT COVERAGE:

This research report on the global spinal implants market has been segmented and sub-segmented based on the product, technology, and region.

Spinal Implants Market - By Technology:

• Spinal Fusion and Fixation Technologies
• Vertebral Compression Fracture Treatment
• Motion Preservation/Non-Fusion Technologies
• Spinal Decompression
• Y-o-Y Growth Analysis, By Technology
• Market Attractiveness Analysis, By Technology
• Market Share Analysis, By Technology

Based on technology, the motion preservation/non-fusion segment is anticipated to capture the leading share of the global implants market and is expected to witness the highest CAGR during the forecast period. The benefits of motion preservation technologies such as shorter hospital stays, faster recovery times, and lower risk of adjacent level degeneration, is one of the major factors propelling

the segmental growth. The segment's growth is further driven by the rising preference for motion preservation technologies among patients and healthcare providers, the growing aging population and the increasing patient population suffering from spinal disorders. The emergence of advanced non-fusion devices due to technological innovations further promotes the segment's growth rate.

The spinal fusion and fixation technologies segment is predicted to hold a substantial share of the global market during the forecast period. The growing prevalence of spinal stenosis and degenerative disc diseases are majorly driving segmental growth as spinal fusion is a widely used treatment for these diseases

Spinal Implants Market - By Product:

• Thoracic Fusion and Lumbar Fusion Devices                                             
  • Posterior Thoracic Fusion and Lumbar Fusion Devices                      
  • Interbody Thoracic Fusion and Lumbar Fusion Devices                    
    • By Approach   
    • Anterior Lumbar Interbody Fusion Devices
    • Posterior Lumbar Interbody Fusion Devices
    • Transforaminal Lumbar Interbody Fusion Devices
    • Axial Lumbar Interbody Fusion Devices
    • By Material      
    • Non-Bone Interbody Fusion Devices
    • Bone Interbody Fusion Devices
    • Anterior Thoracic Fusion and Lumbar Fusion Devices    
  • Cervical Fusion Devices                  
    • Anterior Cervical Fusion             
    • Anterior Cervical Plates
    • Cervical Interbody Fusion Devices
    • Anterior Cervical Screw Systems
    • Posterior Cervical Fusion           
    • Posterior Cervical Plates
    • Posterior Cervical Screws
    • Posterior Cervical Rods
  • Spine Biologics                   
    • Demineralized Bone Matrix      
    • Bone Morphogenetic Proteins
    • Bone Substitutes          
    • Machined Bones           
    • Cell-Based Matrices     
    • Allografts          
  • Vcf Treatment Devices                   
    • Balloon Kyphoplasty Devices   
    • Vertebroplasty Devices              
  • Spinal Decompression                    
    • Discectomy      
    • Laminoplasty, Laminectomy, and Laminotomy
    • Foraminotomy and Foraminectomy     
    • Facetectomy   
    • Corpectomy    
  • Non-Fusion Devices                        
    • Dynamic Stabilization Devices  
    • Interspinous Process Spacers
    • Pedicle-Based Dynamic Rod Devices
    • Facet Replacement Products
    • Artificial Discs  
    • Artificial Cervical Discs
    • Artificial Lumbar Discs
    • Annulus Repair Devices              
    • Nuclear Disc Prostheses             
  • Spine Bone Stimulators                  
    • Non-Invasive Spine Bone Stimulators  
    • Pulsed Electromagnetic Field Devices
    • Cc and Cmf Devices
    • Invasive Spine Bone Stimulators            
  • Y-o-Y Growth Analysis, By Product                                               
  • Market Attractiveness Analysis, By Product                                             
  • Market Share Analysis, By Product

Based on product type, the thoracic fusion and lumbar fusion device segment occupied the major share of the global spinal implants market in 2022 and is anticipated to register a promising CAGR during the forecast period. Under the sub-segments, the anterior lumbar interbody fusion devices sub-sub-segment is predicted to hold a considerable share of the global market and is also expected to showcase the fastest CAGR during the forecast period. The rising adoption of minimally invasive surgeries and increasing awareness regarding the advantages of faster recovery times and shorter hospital stays among patients and healthcare providers are fuelling segmental growth. Furthermore, the growing patient count suffering from spinal degenerative diseases and the rapid adoption of technological developments to develop advanced and effective spinal implants are promoting the segment's growth rate.

The cervical fusion devices segment is estimated to occupy a substantial share of the global market during the forecast period. The growing number of people suffering from degenerative disc disease and herniated discs in the cervical region is fuelling segmental growth. Under the sub-segments, the anterior cervical fusion sub-sub-segment held the major share of the market in 2022.

The spine biologics segment is predicted to witness a healthy CAGR during the forecast period owing to the rising demand for bone graft substitutes and bone morphogenetic proteins (BMPs) for spinal fusion surgeries.

The VCF treatment devices segment is expected to hold a considerable share of the worldwide market during the forecast period owing to the increasing patient population suffering from osteoporosis and vertebral compression fractures.

Spinal Implants Market - By Surgery Type:

• Open Surgeries
• Minimally Invasive Surgeries        

Based on surgery type, the minimally invasive surgeries segment held the major share of the global spinal implants market in 2022 and the domination of the segment is expected to continue during the forecast period. Due to the benefits of minimally invasive surgeries such as reduced blood loss, faster

recovery, and fewer post-operative complications, the adoption of minimally invasive surgeries is growing, which is contributing to segmental growth. Compared to open surgeries, minimally invasive surgeries offer better patient outcomes and discomfit causes minimal pain. The growing patient population suffering from spinal disorders and the rapid adoption of technological developments towards the development of advanced surgical tools and techniques are further fuelling the segment’s growth rate.

The open surgeries segment is anticipated to hold a substantial share of the worldwide market during the forecast period. Open surgeries are performed for severe spinal disorders.

Spinal Implants Market - By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Geographically, the North American spinal implants market held the largest share of the worldwide market in 2021 and the dominance of the region is expected to continue during the forecast period. The growth of the North American region is majorly driven by the increasing patient population suffering from spinal disorders, the rising adoption of technological developments to develop advanced and effective spinal implants and the presence of pharmaceutical and biotechnological companies. The U.S spinal implants market had the major share of the North American market in 2021, followed by Canada. The growing number of accidents happening in the United States and the growing number of product launches are supporting the market growth in the U.S. In addition, increasing R&D activities by the market participants to being advanced and effective spinal implants, a growing number of spinal implant procedures are promoting the U.S. spinal implants market growth. The Canadian spinal implants market is anticipated to grow at a healthy CAGR during the forecast period owing to the increasing patient population suffering from obesity and the increasing adoption of technologically well-developed spinal implants.

The European spinal implants market held a substantial share of the global market in 2021 and is expected to grow at a noteworthy CAGR during the forecast period. The growing aging population, increasing demand for spinal implants and increasing patient population suffering from spinal disorders are propelling the European market growth. The growing funding and investments by the key market players to bring novel spinal implants to the market in Europe are supporting the market growth in Europe. The UK spinal implants market captured a major share of the European market in 2021. According to the statistics published by the Spinal Injuries Association, an estimated 2500 new cases of spinal cord injuries register per year. Overall, an estimated 50,000 people in the UK are suffering from spinal cord injuries. On the other hand, the German spinal implants market is estimated to hold a considerable share of the European market during the forecast period. The growing patient population suffering from spinal disorders and increasing efforts from the manufacturers to promote the awareness of spinal implants among healthcare providers are boosting the spinal implants market growth in Germany. The Italian spinal implants market is expected to witness the fastest CAGR during the forecast period owing to the growing aging population and growing adoption of minimally invasive surgeries.

However, the APAC spinal implants market is anticipated to witness a promising CAGR during the forecast period. The growth of the APAC market is majorly driven by the increasing number of people

suffering from herniated discs, degenerative disc disease, and spinal stenosis among the APAC countries is majorly driving the APAC spinal implants market growth. In addition, the growing aging population, increasing healthcare expenditure and rapid adoption of technological developments are further promoting the spinal implants market growth in APAC. The Chinese market had a major share of the APAC market in 2021. Factors such as the increasing population and rising demand for spinal implant procedures are propelling the Chinese market growth. India and Japan are predicted to hold a substantial share of the APAC market during the forecast period.

The Latin American spinal implants market is estimated to hold a considerable share of the global market during the forecast period. Brazil, Mexico and Argentina are predicted to occupy a major share of the Latin American market during the forecast period.

The MEA spinal implants market is predicted to witness a moderate CAGR in the coming years.

KEY MARKET PLAYERS:

Key market participants leading the global spinal implants market profiled in this report are Medtronic, plc (Ireland), DePuy Synthes (U.S.), Stryker Corporation (U.S.), NuVasive, Inc. (the U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Globus Medical, Inc. (U.S.), Alphatec Holdings, Inc. (U.S.), Orthofix International N.V.(Netherlands), K2M Group Holdings, Inc. (U.S.) and RTI Surgical, Inc. (U.S.).

NOTABLE HAPPENINGS IN THIS MARKET IN THE RECENT PAST:

• CarboFix Company developed a product called CarboClear Carbon Fiber vertebral body replacement (VBR) system to expand its spinal product portfolio, which the FDA approved on Oct 17, 2019. 
• DePuy Synthes launched the CONDUIT interbody platform integrated with EIT cellular titanium technology in September 2019. The elaborative portfolio included a 3D printed titanium interbody implant, which is applied to imitate natural bone and assist spinal fusion.
• Renovis’ Surgical Technologies Inc. collaborated with Kyocera Corporation in January 2019. Kyocera has expanded its product portfolio with this collaboration related to spinal and artificial joint products.
• Wishbone Medical acquired CSpine Inc. in May 2019. Wishbone has expanded its product portfolio regarding orthopedic and spinal instruments and implants with the acquisition of Cspine.